[Differentiation of human promyelocytic leukemia (HL-60) cells induced by new synthetic retinoids 4-(ethoxycarbophenyl) retinamide and 4-(hydroxycarbophenyl) retinamide].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology*; D016177:Macrophage-1 Antigen; D009580:Nitroblue Tetrazolium / Q000378:metabolism; D011951:Receptors, Complement / Q000032:analysis; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000494:pharmacology
D000970:Antineoplastic Agents; D016177:Macrophage-1 Antigen; D011951:Receptors, Complement; D009580:Nitroblue Tetrazolium; C036476:4-(carboethoxyphenyl)retinamide; D014212:Tretinoin; C045860:N-(4-carboxyphenyl)retinamide; D004121:Dimethyl Sulfoxide